Salmonella expressing detoxified lipopolysaccharide is immunogenic and protective both as an attenuated vaccine and for delivery of foreign antigens

Expert Review of Vaccines

Volumn 10, Issue 12, 2011, Pages 1679-1682

  Galen, James E ^a,b   Simon, Raphael ^a,b   Ernst, Robert K ^c  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

Author keywords

delayed attenuation; endotoxin; foreign antigen; monophosphoryl lipid A; protection; Salmonella; vaccine

Indexed keywords

BACTERIAL ANTIGEN; LIPOPOLYSACCHARIDE; LIVE VACCINE; SALMONELLOSIS VACCINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; DNA MODIFICATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SALMONELLA TYPHIMURIUM;

EID: 81355147403     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.11.155     Document Type: Article

References (16)

1. Levine MM, Galen JE, Pasetti MF, Sztein MB. Attenuated strains of Salmonella enterica serovars Typhi and Paratyphi as live oral vaccines against enteric fever. In: New Generation Vaccines (4th Edition). Levine MM, Dougan G, Good MF et al (Eds.) Informa Healthcare, NY, USA, 497-505 (2010).
2. Dilts DA, Riesenfeld-Orn I, Fulginiti JP et al. Phase 1 clinical trials of aroAaroD and aroAaroDhtrA attenuated S. typhi vaccines; effect of formulation on safety and immunogenicity. Vaccine 18(15), 1473-1484 (2000). (Pubitemid 30017828)
3. Levine MM, Herrington D, Murphy JR et al. Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans. J. Clin. Invest. 79(3), 888-902 (1987). (Pubitemid 17050917)
4. Hohmann EL, Oletta CA, Miller SI. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Vaccine 14(1), 19-24 (1996). (Pubitemid 26046542)
5. Hohmann EL, Oletta CA, Killeen KP, Miller SI. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. J. Infect. Dis. 173(6), 1408-1414 (1996). (Pubitemid 26286800)
6. Kong Q, Six DA, Roland KL et al. Salmonella synthesizing 1-monophosphorylated lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity. J. Immunol. 187(1), 412-423 (2011).
7. Roy MF, Lariviere L, Wilkinson R et al. Incremental expression of TLR4 correlates with mouse resistance to Salmonella infection and fine regulation of relevant immune genes. Genes Immun. 7(5), 372-383 (2006). (Pubitemid 44111642)
8. Nagai Y, Akashi S, Nagafuku M et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3(7), 667-672 (2002). (Pubitemid 34752476)
9. Casella CR, Mitchell TC. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol. Life Sci. 65(20), 3231-3240 (2008).
10. Didierlaurent AM, Morel S, Lockman L et al. AS04, an aluminum salt- and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J. Immunol. 183(10), 6186-6197 (2009).
11. Garcon N, Segal L, Tavares F, Van MM. The safety evaluation of adjuvants during vaccine development: the AS04 experience. Vaccine 29(27), 4453-4459 (2011).
12. Khan S, Chatfield S, Stratford R et al. Ability of SPI2 mutant of S. typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans. Vaccine 25(21), 4175-4182 (2007). (Pubitemid 46635952)
13. Tacket CO, Galen J, Sztein MB et al. Safety and immune responses to attenuated Salmonella enterica serovar Typhi oral live vector vaccines expressing tetanus toxin fragment C. Clin. Immunol. 97(2), 146-153 (2000).
14. Curtiss R 3rd, Xin W, Li Y et al. New technologies in using recombinant attenuated Salmonella vaccine vectors. Crit. Rev. Immunol. 30(3), 255-270 (2010).
15. Li Y, Wang S, Scarpellini G et al. Evaluation of new generation Salmonella enterica serovar Typhimurium vaccines with regulated delayed attenuation to induce immune responses against PspA. Proc. Natl Acad. Sci. USA 106(2), 593-598 (2009).
16. Wang S, Li Y, Scarpellini G et al. Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity. Infect. Immun. 78(9), 3969-3980 (2010).